Sickness behavior induced by endotoxin can be mitigated by the dietary soluble fiber, pectin, through up-regulation of IL-4 and Th2 polarization

Brain, Behavior, and Immunity

Volumn 24, Issue 4, 2010, Pages 631-640

  Sherry, Christina L ^a   Kim, Stephanie S ^a   Dilger, Ryan N ^a   Bauer, Laura L ^a   Moon, Morgan L ^a   Tapping, Richard I ^b   Fahey, George C ^a   Tappenden, Kelly A ^a   Freund, Gregory G ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Cytokines; Dietary fiber; IL 4; Macrophage alternative activation; Sickness behavior; Th1 Th2

Indexed keywords

ARGINASE 1; CELL PROTEIN; CELLULOSE; CONCANAVALIN A; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MYELOID DIFFERENTIATION FACTOR 88; NITRATE; PECTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; YM1 PROTEIN; ANTIDIARRHEAL AGENT; CYTOKINE; INTERLEUKIN 6; MYD88 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBER; FOOD INTAKE; ILEUM; ILLNESS BEHAVIOR; IMMUNE RESPONSE; INNATE IMMUNITY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; TH2 CELL; UPREGULATION; ANIMAL; C57BL MOUSE; CLASSIFICATION; COMPARATIVE STUDY; CYTOLOGY; DEFICIENCY; DIET THERAPY; DIETARY FIBER; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; INNERVATION; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; METABOLISM; PHARMACOLOGY; POLYMERASE CHAIN REACTION; PROCEDURES;

ANIMALS; ANTIDIARRHEALS; CYTOKINES; DIET THERAPY; DIETARY FIBER; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ILEUM; ILLNESS BEHAVIOR; INJECTIONS, INTRAPERITONEAL; INTERFERON-GAMMA; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-12; INTERLEUKIN-1BETA; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PECTINS; POLYMERASE CHAIN REACTION; SPLEEN; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 77951878716     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.01.015     Document Type: Article

References (55)

1. Ansel K.M., Djuretic I., Tanasa B., Rao A. Regulation of Th2 differentiation and Il4 locus accessibility. Annu. Rev. Immunol. 2006, 24:607-656.
2. Arend W.P., Palmer G., Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 2008, 223:20-38.
3. Bowen H., Kelly A., Lee T., Lavender P. Control of cytokine gene transcription in Th1 and Th2 cells. Clin. Exp. Allergy 2008, 38:1422-1431.
4. Burgess W., Gheusi G., Yao J., Johnson R.W., Dantzer R., Kelley K.W. Interleukin-1beta-converting enzyme-deficient mice resist central but not systemic endotoxin-induced anorexia. Am. J. Physiol. 1998, 274:R1829-R1833.
5. Cavaglieri C.R., Nishiyama A., Fernandes L.C., Curi R., Miles E.A., Calder P.C. Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci. 2003, 73:1683-1690.
6. Cote-Sierra J., Foucras G., Guo L., Chiodetti L., Young H.A., Hu-Li J., Zhu J., Paul W.E. Interleukin 2 plays a central role in Th2 differentiation. Proc. Natl. Acad. Sci. USA 2004, 101:3880-3885.
7. Cox M.-A.A., Jackson J., Stanton M., Rojas-Triana A., Bober L., Laverty M., Yang X., Zhu F., Liu J., Wang S., Monsma F., Vassileva G., Maguire M., Gustafson E., Bayne M., Chou C.-C.C., Lundell D., Jenhby C.-H.H. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J. Gastroenterol. 2009, 44:5549-5557.
8. Dantzer R. Cytokine, sickness behavior, and depression. Neurol. Clin. 2006, 24:441-460.
9. Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur. J. Pharmacol. 2004, 500:399-411.
10. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
11. Fowell D.J. Signals for the execution of Th2 effector function. Cytokine 2009, 46:1-6.
12. Galvez J., Rodriguez-Cabezas M.E., Zarzuelo A. Effects of dietary fiber on inflammatory bowel disease. Mol. Nutr. Food Res. 2005, 49:601-608.
13. Gassull M.A. Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease. Aliment. Pharmacol. Ther. 2006, 24(Suppl. 3):90-95.
14. Ghadimi D., Folster-Holst R., de Vrese M., Winkler P., Heller K.J., Schrezenmeir J. Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology 2008, 213:677-692.
15. Gilmour J., Lavender P. Control of IL-4 expression in T helper 1 and 2 cells. Immunology 2008, 124:437-444.
16. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003, 3:23-35.
17. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953-964.
18. Groff J.L., Gropper S.S. Advanced Nutrition and Human Metabolism 1999, Wadsworth, Belmont, CA.
19. Han S., Lu J., Zhang Y., Cheng C., Li L., Han L., Huang B. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region. Immunol. Lett. 2007, 108:143-150.
20. Horn K.D. Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS). QJM 1998, 91:265-277.
21. Jain S., Yadav H., Sinha P.R. Probiotic dahi containing lactobacillus casei protects against Salmonella enteritidis infection and modulates immune response in mice. J. Med. Food 2009, 12:576-583.
22. Jain S., Yadav H., Sinha P.R., Marotta F. Modulation of cytokine gene expression in spleen and peyer's patches by feeding dahi containing probiotic lactobacillus casei in mice. J. Dig. Dis. 2009, 10:49-54.
23. Johnson D.R., O'Connor J.C., Dantzer R., Freund G.G. Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness. Proc. Natl. Acad. Sci. USA 2005, 102:15184-15189.
24. Johnson D.R., O'Connor J.C., Hartman M.E., Tapping R.I., Freund G.G. Acute hypoxia activates the neuroimmune system which diabetes exacerbates. J. Neurosci. 2007, 27:1161-1166.
25. Kanauchi O., Oshima T., Andoh A., Shioya M., Mitsuyama K. Germinated barley foodstuff ameliorates inflammation in mice with colitis through modulation of mucosal immune system. Scand. J. Gastroenterol. 2008, 43:1346-1352.
26. Kenny E.F., O'Neill L.A. Signalling adaptors used by toll-like receptors: an update. Cytokine 2008, 43:342-349.
27. Kindt T.J., Goldsby R.A., Osborne B.A. Immunology 2007, W.H. Freeman and Company, New York, NY.
28. Knopp R.H., Superko H.R., Davidson M., Insull W., Dujovne C.A., Kwiterovich P.O., Zavoral J.H., Graham K., O'Connor R.R., Edelman D.A. Long-term blood cholesterol-lowering effects of a dietary fiber supplement. Am. J. Prev. Med. 1999, 17:18-23.
29. Kruisbeek A.M. Isolation of mouse mononuclear cells. Current Protocols in Immunology 2000, Wiley. J.E. Coligan, B. Bierer, D.H. Margulies, E.M. Shevach, W. Strober, R. Coico (Eds.).
30. Kuzmuk K.N., Swanson K.S., Tappenden K.A., Schook L.B., Fahey G.C. Diet and age affect intestinal morphology and large bowel fermentative end-product concentrations in senior and young adult dogs. J. Nutr. 2005, 135:1940-1945.
31. Lim B.O., Lee S.H., Park D.K., Choue R.W. Effect of dietary pectin on the production of immunoglobulins and cytokines by mesenteric lymph node lymphocytes in mouse colitis induced with dextran sulfate sodium. Biosci. Biotechnol. Biochem. 2003, 67:1706-1712.
32. Marlett J.A., McBurney M.I., Slavin J.L. Position of the American dietetic association health implications of dietary fiber. J. Am. Diet. Assoc. 2002, 102:993-1000.
33. Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 2009, 27:451-483.
34. Mills C.D., Kincaid K., Alt J.M., Heilman M.J., Hill A.M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 2000, 164:6166-6173.
35. Mosser D.M. The many faces of macrophage activation. J. Leukoc. Biol. 2003, 73:209-212.
36. O'Connor J.C., Sherry C.L., Guest C.B., Freund G.G. Type 2 diabetes impairs insulin receptor substrate-2-mediated phosphatidylinositol 3-kinase activity in primary macrophages to induce a state of cytokine resistance to IL-4 in association with overexpression of suppressor of cytokine signaling-3. J. Immunol. 2007, 178:6886-6893.
37. Mukherjee S., Chen L.Y., Papadimos T.J., Huang S., Zuraw B.L., Pan Z.K. Lipopolysaccharide-driven Th2 cytokine production in macrophages is regulated by both MyD88 and TRAM. J. Biol. Chem. 2009, 284:29391-29398.
38. O'Connor J.C., Satpathy A., Hartman M.E., Horvath E.M., Kelley K.W., Dantzer R., Johnson R.W., Freund G.G. IL-1beta-mediated innate immunity is amplified in the db/db mouse model of type 2 diabetes. J. Immunol. 2005, 174:4991-4997.
39. Re F., Muzio M., De Rossi M., Polentarutti N., Giri J.G., Mantovani A., Colotta F. The type II " receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J. Exp. Med. 1994, 179:739-743.
40. Rittirsch D., Flierl M.A., Ward P.A. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 2008, 8:776-787.
41. Roediger W.E. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980, 21:793-798.
42. Rose D.J., DeMeo M.T., Keshavarzian A., Hamaker B.R. Influence of dietary fiber on inflammatory bowel disease and colon cancer: importance of fermentation pattern. Nutr. Rev. 2007, 65:51-62.
43. Scott K., Duncan S., Flint H. Dietary fibre and the gut microbiota. Nutr. Bull. 2008, 33:201.
44. Sealy L., Chalkley R. The effect of sodium butyrate on histone modification. Cell 1978, 14:115-121.
45. Sherry C.L., Kim S.S., Freund G.G. Accelerated recovery from acute hypoxia in obese mice is due to obesity-associated up-regulation of interleukin-1 receptor antagonist (IL-1RA). Endocrinology 2009, 150:2660-2667.
46. Sherry C.L., Kramer J.M., York J.M., Freund G.G. Behavioral recovery from acute hypoxia is reliant on leptin. Brain Behav. Immun. 2009, 23:169-175.
47. Sherry C.L., O'Connor J.C., Kramer J.M., Freund G.G. Augmented lipopolysaccharide-induced TNF-α production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 map kinase. J. Immunol. 2007, 178:663-670.
48. Streck E.L., Comim C.M., Barichello T., Quevedo J. The septic brain. Neurochem. Res. 2008, 33:2171-2177.
49. Torres M.I., Rios A. Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. World J. Gastroenterol. 2008, 14:1972-1980.
50. Valapour M., Guo J., Schroeder J.T., Keen J., Cianferoni A., Casolaro V., Georas S.N. Histone deacetylation inhibits IL4 gene expression in T cells. J. Allergy Clin. Immunol. 2002, 109:238-245.
51. Varin A., Gordon S. Alternative activation of macrophages: immune function and cellular biology. Immunobiology 2009, (Epub ahead of print).
52. Wen L., Ley R.E., Volchkov P.Y., Stranges P.B., Avanesyan L., Stonebraker A.C., Hu C., Wong F.S., Szot G.L., Bluestone J.A., Gordon J.I., Chervonsky A.V. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 2008, 455:1109-1113.
53. Wynn T.A. IL-13 effector functions. Annu. Rev. Immunol. 2003, 21:425-456.
54. Wong J.M., de Souza R., Kendall C.W., Emam A., Jenkins D.J. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 2006, 40:235-243.
55. Yamashita M., Ukai-Tadenuma M., Miyamoto T., Sugaya K., Hosokawa H., Hasegawa A., Kimura M., Taniguchi M., DeGregori J., Nakayama T. Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci. J. Biol. Chem. 2004, 279:26983-26990.